Search Results

OSI Systems, Inc. announced that its Healthcare division, Spacelabs Healthcare®, has received an order valued at approximately $5 million to provide patient monitoring solutions and related supplies and accessories to a U.S. based hospital.

Spacelabs Healthcare®, a division of OSI Systems, Inc., and Masimo announced that they have extended their partnership in patient monitoring to integrate SET® pulse oximetry, NomoLine® capnography, rainbow SET® Pulse CO-Oximetry, SedLine® brain function monitoring, and O3® regional oximetry into select Spacelabs multi-parameter monitors.

OSI Systems, Inc. announced that its Healthcare division, Spacelabs Healthcare®, has received an order valued at approximately $4 million to provide patient monitoring solutions and related accessories to a U.S. based hospital.

Spacelabs Healthcare (the “Company” or “Spacelabs”), a division of OSI Systems, Inc. (“OSI Systems”) (NASDAQ: OSIS), today announced the release of Lifescreen™ Pro event screening system. Lifescreen Pro expands the Company’s non-invasive cardiology offerings, which include Spacelabs Pathfinder SL ambulatory ECG analysis system.

Sanofi looks to follow a deep history of Big Pharma offloading their consumer healthcare businesses.

Sanofi will sell a 50% controlling stake in consumer healthcare unit Opella to private equity firm CD&R, with the French government taking a stake as well to ensure the business remains in the county.